Hyperemesis gravidarum; GDF15; GFRAL; PUQE-24; nausea and vomiting of pregnancy; ELISA; Iraq
American Journal of Medical and Natural Sciences · 2026
DOI: 10.70604/ajmns.v7i2.39 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical and Natural Sciences, 2026. Verfasst von Durar Kamil Jabbar. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hyperemesis gravidarum (HG) is the severe end of nausea and vomiting in pregnancy. Growth differentiation factor 15 (GDF15), released by the placenta, acts on the brainstem emesis centre via the GFRAL receptor. Recent evidence from European cohorts places GDF15 at the centre of HG pathophysiology, yet no Iraqi data have been reported.
Objective
To compare serum GDF15 between Iraqi women with HG and pregnant controls, and to explore its association with symptom severity.
Methods
In this case–control study at Al-Diwaniyah Teaching Hospital, 80 women with HG (Windsor definition) and 80 pregnant controls at 7–14 weeks’ gestation were enrolled. Severity was graded with the PUQE-24 instrument. Serum GDF15 was measured by sandwich ELISA. Groups were compared with the Mann–Whitney U test; Spearman correlation between GDF15 and PUQE-24 within HG was computed with a bootstrap confidence interval; and multivariable models of ln(GDF15) used HC3-robust standard errors.
Results
Median serum GDF15 was 14.15 ng/mL (Q1–Q3 10.64–16.60) in HG and 10.57 ng/mL (7.53–13.25) in controls (p < 0.001). The adjusted GDF15 ratio for HG versus controls was 1.373 (95% CI 1.218–1.547; p < 0.001). Within HG, Spearman's ρ between GDF15 and PUQE-24 was 0.235 (bootstrap CI −0.004 to 0.462; p = 0.036). Each PUQE-24 point corresponded to a GDF15 ratio of 1.058 (95% CI 1.003–1.116; p = 0.040). Geometric mean GDF15 rose from 9.99 ng/mL in controls through 12.38 in moderate HG to 14.99 ng/mL in severe HG (Kruskal–Wallis p < 0.001).
Conclusion
Serum GDF15 was significantly higher in Iraqi women with HG than in controls, with a weak positive trend with symptom severity that did not reach significance by the bootstrap CI criterion. These findings support the GDF15–GFRAL model and further investigation of GDF15 as a severity marker in this population.
Zitieren
APA
Jabbar, D. K. (2026). Hyperemesis gravidarum; GDF15; GFRAL; PUQE-24; nausea and vomiting of pregnancy; ELISA; Iraq. American Journal of Medical and Natural Sciences. https://doi.org/10.70604/ajmns.v7i2.39
Vancouver
Jabbar DK. Hyperemesis gravidarum; GDF15; GFRAL; PUQE-24; nausea and vomiting of pregnancy; ELISA; Iraq. American Journal of Medical and Natural Sciences. 2026. doi:10.70604/ajmns.v7i2.39
BibTeX
@article{Jabbar2026,
author = {Jabbar, Durar Kamil},
title = {Hyperemesis gravidarum; GDF15; GFRAL; PUQE-24; nausea and vomiting of pregnancy; ELISA; Iraq},
journal = {American Journal of Medical and Natural Sciences},
year = {2026},
doi = {10.70604/ajmns.v7i2.39}
}
EUVIMED